An issue was discovered in Fresenius Kabi PharmaHelp 5.1.759.0 allows attackers to gain escalated privileges via via capture of user login information.
Conclusion & alert: CVE-2022-45611 is rated Moderate Risk (59.7/100): CVSS Critical severity, with medium exploitation likelihood (EPSS 0.94%).Mandatory action: Review affected assets and schedule remediation.
Risk is dynamic; we continuously reassess and refresh what is shown on this page as upstream context changes.
Exploit prediction scoring system (EPSS) score for CVE-2022-45611
EPSS lead: Daily EPSS estimates relative likelihood of exploitation; percentile ranks this CVE among scored vulnerabilities (higher = more severe relative rank).